Ali Rafat

7PUBLICATIONS
10CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 29, 2026
Targeting the PI3K/AKT/mTOR pathway in gastrointestinal cancers: a comprehensive review of mechanisms, preclinical evidence, and clinical challenges.

|Aug 27, 2026
Inflammatory and Immune Microenvironment in Myeloproliferative Neoplasms: Pathogenic Mechanisms and Therapeutic Opportunities.

|Jun 25, 2026
c-Myc-Induced Therapy Resistance in Leukemia: Mechanisms and Emerging Therapeutic Opportunities.

|May 27, 2026
Targeting the WNT/β-Catenin Pathway in Hematological Malignancies: From Molecular Pathogenesis to Emerging Therapeutic Strategies.

|Jun 28, 2025
Role of Tigecycline in radiation sensitivity in colorectal cancer cell line.

Sepideh Hassanpour Khodaei, Shahnaz Sabetkam, Zeinab Mazloumi

|Feb 01, 2023
The Effect of Telomerase Inhibition on NK Cell Activity in Acute Myeloid Leukemia.

Khadijeh Dizaji Asl, Ali Rafat, Ali Akbar Movassaghpour

Pageof 2

Frequent Collaborators

3 joint publications

Reza Nejati

2 joint publications

Khadijeh Dizaji Asl

2 joint publications

Seyyede Sepide Ashraf Moosavi

1 joint publications

Ali Akbar Movassaghpour